MindMed is a New York-based company that focuses on improving patient outcomes through the development of novel drug candidates and digital therapeutics. With a mission to unlock the therapeutic potential of psychedelics and other innovative compounds, MindMed aims to address unmet patient needs in the fields of psychiatry, addiction, pain, and neurology.
As a global leader in brain health, MindMed utilizes industry-leading drug development expertise to advance its pipeline of diverse therapeutic programs. With a world-class team of drug developers and digital medicine experts, the company is dedicated to providing innovative solutions for the major unmet medical needs in brain health disorders.
Generated from the website